Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology

NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=qfE51WWfjMaybVuxxBJuINJ_Q2zbCf8U7ZJnBtbpFv-ga6bkJohCFH4MAaDkLtrgZ40da2pIcd_NYzdbVWe8VtjmoAnuAxTRo-oTLMVoB7w= (Nasdaq: INBS) ('INBS' or the 'Company'), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it is [...]